(Worthy News) – The Food and Drug Administration (FDA) requested Monday for the courts to give them until 2076 to review and fully release the documents pertaining to the approval of the Pfizer BioNTech COVID-19 vaccine.
The FDA denied Sept. 9 a
request for an expedited release of the vaccine’s approval records from a group of doctors and scientists, the Public Health Medical Professionals for Transparency (
PHMPT). The PHMPT has since filed a
lawsuit against the FDA for failure to complete their Freedom of Information Act (FOIA) request.
The agency had determined that there were a total of 329,000 pages that needed to be reviewed in order to fulfill the plaintiff’s FOIA request, and proposed that they would be able to “process and produce the non-exempt portions of responsive records at a rate of 500 pages per month.” The FDA said they would provide the plaintiff with prioritized documents and release the non-exempt portions of the records on a “rolling basis.” This rate of review places the FDA’s release of the documents at nearly 55 years. [ Source: Daily Caller (Read More…) ]
We're being CENSORED ... HELP get the WORD OUT! SHARE!!!
Latest Worthy News
Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.
